Please assess the completion status of the following clinical trial:

Trial Title: Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~• Patients age 3 - 17 undergoing adenotonsillectomy~Exclusion Criteria:~* Down syndrome~* History of coagulopathy~* Craniofacial abnormalities other than plagiocephaly or submucous cleft palate (SMCP)~* Caregivers who cannot speak, read, or write in English proficiently~* Patients who take opioids during the enrollment period~* Patients who take chronic opioids~* Pregnancy~* Allergy to or contraindication for taking any of the study medications~* Patients who have the inability to communicate~* Patients who have the inability to localize pain

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Opioid pain control (Type: EXPERIMENTAL): Patients in this group will be receiving triple therapy for pain control with oxycodone, acetaminophen, and ibuprofen. They will be asked to complete a pain diary which will be used to determine the level of pain control achieved with this regimen. The diary will be completed by post-operative day 14. A post-operative appointment between 4-8 weeks will be scheduled and the patient and caregiver will return the pain diary or by email/mail if no appointment was scheduled. Families will receive an opioid disposal education document.
- Opioid pain control + Disposal Pouch (Type: EXPERIMENTAL): Patients in this group will be receiving triple therapy for pain control with oxycodone, acetaminophen, and ibuprofen. They will be asked to complete a pain diary which will be used to determine the level of pain control achieved with this regimen. The diary will be completed by post-operative day 14. A post-operative appointment between 4-8 weeks will be scheduled and the patient and caregiver will return the pain diary or by email/mail if no appointment was scheduled. Half of the families randomized to the opioid group will be further randomized to receive an opioid disposal bag + an opioid disposal education document. The pouch is a drug deactivation disposal pouch to dispose the opioid at home.
- Non-opioid pain control (Type: ACTIVE_COMPARATOR): Patients in this group will be receiving therapy for pain control with acetaminophen and ibuprofen only. They will be asked to complete a pain diary which will be used to determine the level of pain control achieved with this regimen. The diary will be completed by post-operative day 14. A post-operative appointment between 4-8 weeks will be scheduled and the patient and caregiver will return the diary or by email/mail if no appointment was scheduled.

Based on this trial design, predict the completion outcome and termination type (if applicable).